NLRP3 and steatosis: In the present study, after characterization of roles in which NLRP3 inflammasomes play in NASH, we also examined whether FTZ prevents NASH development by targeting the effects of NLRP3 inflammasome activation on both inflammatory response and steatosis in the liver.